Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells()

Despite the tremendous advances in the treatment of childhood solid tumors, rhabdomyosarcoma (RMS) continues to provide a therapeutic challenge. Children with metastatic or relapsed disease have a disease-free survival rate under 30%. Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, Alicia M., Stafman, Laura L., Garner, Evan F., Mruthyunjayappa, Smitha, Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925808/
https://www.ncbi.nlm.nih.gov/pubmed/27567948
http://dx.doi.org/10.1016/j.tranon.2016.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925808/
https://www.ncbi.nlm.nih.gov/pubmed/27567948
http://dx.doi.org/10.1016/j.tranon.2016.06.001

Ejemplares similares